Safety, tolerability, and preliminary efficacy of 48 weeks of etravirine therapy in a phase IIb dose-ranging study involving treatment-experienced patients with HIV-1 infection

Authors
Publication date
1 October 2008
Publisher
'University of Chicago Press'
Doi

    Abstract

    SCOPUS: ar.jinfo:eu-repo/semantics/publishe

      Similar works

      Full text

      thumbnail-image

      Available Versions

      DI-fusion

      redirect
      oaioai:dipot.ulb.ac.be:2013/84615
      Last time updated on 25/07/2012